New immunotherapy drug boosts innate immune system to fight cancer

A newly released study by Jinming Gao, professor of Oncology, Pharmacology, and Otolarynology, shows how a novel, nanoparticle-based drug may be more effective at engaging the body’s innate immune system to fight cancer. The drug’s unique and prolonged binding to the STING protein was associated with longer innate immune activation, demonstrating a more effective T cell response against solid tumors.